The combination of Surmontil (amitriptyline), Vivactil (protriptyline), GHB (gamma-hydroxybutyrate), and Clonazepam presents a notably complicated scenario for individuals and prescribing professionals. Every drug carries its individual risks , and their concurrent use can substantially elevate the possibility of adverse effects. GHB, in particular